Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that Laura Groschen has joined Acadia as the Company’s new Chief Information Officer (CIO). In this role, she will shape and advance the Company’s information technology (IT) strategy, driving continued digital transformation across Acadia’s scaled behavioral health capabilities. As a new member of the Company’s executive leadership team, Groschen will report to Chris Hunter, Chief Executive Officer.
Groschen joins Acadia with over 25 years of experience driving strategic transformation at large healthcare and consumer-focused IT organizations. She most recently served as the Business Unit CIO of Medtronic, a $30 billion global healthcare solutions company, where she led a team supporting information and technology for 20 operating units and global business functions across Medtronic’s locations in 150 countries. With a focus on optimizing business outcomes through technology investments, she also led Medtronic’s IT strategy for mergers, acquisitions and divestures. Prior to Medtronic, she was Business Unit CIO for United Health Group where she led a $4 billion annual revenue practice implementing technology solutions for federal and state governments in support of the Affordable Care Act. Groschen previously held several executive leadership roles for Wells Fargo & Company.
“We are delighted to welcome Laura Groschen to the Acadia executive leadership team in this important new role,” said Hunter. “She brings the right complement of IT and business leadership experience and a strong history of leveraging technology and supporting a culture of innovation for leading healthcare companies. As Acadia continues to grow, we are committed to creating and implementing best-in-class IT solutions that will further enhance the delivery of care and support the patients we serve. Laura will be an integral part of this transformation, and we are excited about our renewed IT focus as we continue to execute our growth strategy.”
About Acadia Healthcare
Acadia is a leading provider of behavioral healthcare services across the United States. Acadia operates a network of 246 behavioral healthcare facilities with approximately 10,800 beds in 39 states and Puerto Rico. With more than 22,500 employees serving approximately 75,000 patients daily, Acadia is the largest stand-alone behavioral healthcare company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.
Last Trade: | US$39.10 |
Daily Change: | 2.01 5.42 |
Daily Volume: | 1,950,624 |
Market Cap: | US$3.630B |
October 30, 2024 July 31, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB